Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Case Report

First Autochthonous case of Emerged Zoonotic Cutaneous Leishmaniasis in Mazandaran Province, Northern Iran: kDNA-PCR Evidence Base

Author(s): Fatemeh Niksolat, Rabeeh Tabaripour, Lotfollah Davoodi and Mahdi Fakhar*

Volume 21, Issue 3, 2021

Published on: 20 July, 2020

Page: [464 - 467] Pages: 4

DOI: 10.2174/1871526520666200720114135

Price: $65

Abstract

Background: In the last decade, several cases of cutaneous leishmaniasis (CL) have been recorded by the provincial health center of Mazandaran Province, northern Iran. However, there is no documented report of autochthonous CL in the province yet.

Case Presentation: The patient, a 59-year-old female, known case of diabetes mellitus, lived in therural area of Kiasar district (in theeastern part of the Mazandaran) with 5 skin lesions suspected of having vasculitis, without ahistory of traveling to the endemic areas of CL,was admitted to Imam Khomeini teaching hospital, Sari. To rule out CL, fine needle aspiration(FNA)procedure was used aseptically for the patient. Laboratory investigations showed Leishman bodies (amastigotes) by direct smear preparation, and species identification confirmed Leishmania major (L. major) by polymerase chain reaction (PCR)molecular method. Accordingly, this is the first documented report of autochthonous CL in Mazandaran Province.

Conclusion: Overall, due to the abundance of probable rodent reservoir hosts and confirmation of infectionof sandflies (Phlebotomus papatasi) withL. major in the Kiasar district, where our patient was livingthere, it seems that CL emerged in the eastern part of the province. Therefore, further studies on rodents and sandflies fauna in terms of emerging leishmanial infection in the area is recommended.

Keywords: Cutaneous leishmaniasis, case report, diabetes mellitus, autochthonous, L. major, PCR, Iran.

Graphical Abstract
[1]
World Health Organization(WHO); Leishmaniasis. Geneva, Switzerland: WHO. 2018. Available from: http://www.who.int/ mediacentre/ factsheets/fs375/en
[2]
World Health Organization(WHO). Framework for action on cutaneous leishmaniasis in the Eastern Mediterranean Region 2014-2018; Regional Office for the Eastern Mediterranean, 2014.
[3]
Duarte, A.A.; Mohsin, S.; Golubnitschaja, O. Diabetes care in figures: current pitfalls and future scenario. EPMA J., 2018, 9(2), 125-131.
[http://dx.doi.org/10.1007/s13167-018-0133-y] [PMID: 29896313]
[4]
Moosazadeh, M; Afsharib, M; Parsaee, MR Clinico-epidemiological features of cutaneous leishmaniasis in Mazandaran Province, northern Iran. Clin. Epidemiol. Glob. Health, 2019, 7, 378-381.
[http://dx.doi.org/10.1016/j.cegh.2018.08.001]
[5]
Gagnier, J.J.; Kienle, G.; Altman, D.G.; Moher, D.; Sox, H.; Riley, D. CARE Group. The CARE guidelines: consensus-based clinical case report guideline development. J. Clin. Epidemiol., 2014, 67(1), 46-51.
[http://dx.doi.org/10.1016/j.jclinepi.2013.08.003] [PMID: 24035173]
[6]
Ziaei Hezarjaribi, H.; Taghavi, M.; Fakhar, M.; Gholami, S. Direct diagnosis of Trichomonas vaginalis infection on archived pap smears using Nested PCR. Acta Cytol., 2015, 59(1), 104-108.
[http://dx.doi.org/10.1159/000369772] [PMID: 25633887]
[7]
Aransay, A.M.; Scoulica, E.; Tselentis, Y. Detection and identification of Leishmania DNA within naturally infected sand flies by seminested PCR on minicircle kinetoplastic DNA. Appl. Environ. Microbiol., 2000, 66(5), 1933-1938.
[http://dx.doi.org/10.1128/AEM.66.5.1933-1938.2000] [PMID: 10788363]
[8]
Reithinger, R.; Dujardin, J.C.; Louzir, H.; Pirmez, C.; Alexander, B.; Brooker, S. Cutaneous leishmaniasis. Lancet Infect. Dis., 2007, 7(9), 581-596.
[http://dx.doi.org/10.1016/S1473-3099(07)70209-8] [PMID: 17714672]
[9]
Ghatee, M.A.; Taylor, W.R.; Karamian, M. The geographical distribution of cutaneous leishmaniasis causative agents in Iran and its neighboring countries, a review. Front. Public Health, 2020, 8, 11.
[http://dx.doi.org/10.3389/fpubh.2020.00011] [PMID: 32133334]
[10]
Successful in zoonosis control programmes, 1st ed; Shirzadi, M.R.; Sharifian, J.; Zeinali, M.; Qarahgozloo, F.; Pourmozaffari, J.; Doosti, S., Eds.; Ministry of Health and Medical Education publications: Tehran, 2009;
[11]
Holakouie-Naieni, K.; Mostafavi, E.; Boloorani, A.D.; Mohebali, M.; Pakzad, R. Spatial modeling of cutaneous leishmaniasis in Iran from 1983 to 2013. Acta Trop., 2017, 166, 67-73.
[http://dx.doi.org/10.1016/j.actatropica.2016.11.004] [PMID: 27836499]
[12]
Gholamrezaei, M.; Mohebali, M.; Hanafi-Bojd, A.A.; Sedaghat, M.M.; Shirzadi, M.R. Ecological Niche Modeling of main reservoir hosts of zoonotic cutaneous leishmaniasis in Iran. Acta Trop., 2016, 160, 44-52.
[http://dx.doi.org/10.1016/j.actatropica.2016.04.014] [PMID: 27150212]
[13]
Kassi, M.; Tareen, I.; Qazi, A.; Kasi, P.M. Fine-needle aspiration cytology in the diagnosis of cutaneous leishmaniasis. Ann. Saudi Med., 2004, 24(2), 93-97.
[http://dx.doi.org/10.5144/0256-4947.2004.93] [PMID: 15323268]
[14]
Al-Jawabreh, A.; Schoenian, G.; Hamarsheh, O.; Presber, W. Clinical diagnosis of cutaneous leishmaniasis: a comparison study between standardized graded direct microscopy and ITS1-PCR of Giemsa-stained smears. Acta Trop., 2006, 99(1), 55-61.
[http://dx.doi.org/10.1016/j.actatropica.2006.07.001] [PMID: 16920056]
[15]
Karamian, M.; Motazedian, M.H.; Fakhar, M.; Pakshir, K.; Jowkar, F.; Rezanezhad, H. Atypical presentation of Old-World cutaneous leishmaniasis, diagnosis and species identification by PCR. J. Eur. Acad. Dermatol. Venereol., 2008, 22(8), 958-962.
[http://dx.doi.org/10.1111/j.1468-3083.2008.02674.x] [PMID: 18363680]
[16]
Shirzadi, M.R.; Gouya, M.M. National guidelines for cutaneous leishmaniasis surveillance in Iran; Ministry of Health and Medical Education: Tehran, 2012, pp. 1-78.
[17]
Doroodgar, A.; Asmar, M.; Razavi, M.R.; Doroodgar, M. Identifying the type of cutaneous leishmaniasis in patients, reservoirs and vectors by RAPD-PCR in Aran & Bidgol district of Esfahan Province during 2006-7. Feyz, 2009, 13(2), 141-6.
[18]
Khajedaluee, M.; Yazdanpanah, M.J.; Seyed Nozadi, S.; Fata, A.; Juya, M.R.; Masoudi, M.H. Epidemiology of cutaneous leishmaniasis in population covered by Mashhad University of Medical Sciences in 2011. MJMS, 2014, 57(4), 647-54.
[19]
Ghavibazou, L.; Hosseini-Vasoukolaei, N.; Enayati, A.A.; Akhavan, A.A.; Motevalli Haghi, F.; Arabi, M.; Fazeli-Dinan, M.; Shemshadian, A. Epidemiological Survey of Cutaneous Leishmaniasis in Mazandaran Province, Northern Iran. Archives of Hygiene Sciences., 2019, 8(3), 178-187.
[http://dx.doi.org/10.29252/ArchHygSci.8.3.178]
[20]
Akbari, M.R. Determination of Leishmania Infection and Specific Confirmation of Leishmaniasis Carrier Sandflies Using Nested PCR and RFLP in Sari, Mazandaran Province. Master thesis. Mazandaran University of Medical Sciences, Sari, 2019.
[21]
Avishai, E.; Yeghiazaryan, K.; Golubnitschaja, O. Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. EPMA J., 2017, 8(1), 23-33.
[http://dx.doi.org/10.1007/s13167-017-0081-y] [PMID: 28620441]
[22]
Zykova, S.N.; Jenssen, T.G.; Berdal, M.; Olsen, R.; Myklebust, R.; Seljelid, R. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes, 2000, 49(9), 1451-1458.
[http://dx.doi.org/10.2337/diabetes.49.9.1451] [PMID: 10969828]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy